TruBridge Past Earnings Performance
Past criteria checks 1/6
TruBridge's earnings have been declining at an average annual rate of -42.1%, while the Healthcare Services industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 5.1% per year. TruBridge's return on equity is 2.5%, and it has net margins of 1.2%.
Key information
-42.11%
Earnings growth rate
-42.16%
EPS growth rate
| Healthcare Services Industry Growth | 1.72% |
| Revenue growth rate | 5.11% |
| Return on equity | 2.46% |
| Net Margin | 1.23% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
Narrative Update • Jun 26
TBRG: Pending IKS Buyout Will Likely Expose Execution Risks
The analyst price target for TruBridge has moved from $15 to $23. Analysts attribute this change to adjustments in fair value assumptions, a lower discount rate, and updated expectations for revenue growth, profit margins, and future P/E.
Narrative Update • Apr 17
TBRG: Potential IKS Deal And EHR Execution Will Shape Future Re Rating
TruBridge's analyst fair value estimate has shifted from $21.00 to $22.00 as analysts update their models around potential IKS-related opportunities, as well as recent mixed price target moves across the Street. Analyst Commentary Bullish Takeaways Bullish analysts point to the potential IKS transaction as aligned with TruBridge's ongoing review of its business.
New Narrative • Apr 16
AI And Global Delivery Expansion Will Reshape Rural Hospital Solutions Over The Next Decade
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and patient care software and services to hospitals, with a focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Apr 14
TruBridge: Potential Takeover Target, Upside Fundamentally Supported
Summary TruBridge, Inc. is undergoing an operational turnaround with margin expansion, rising EBITDA, and a shift to high-quality recurring revenue. A potential $600 million takeover by Inventurus Knowledge Systems offers a 36–40% premium to current prices but introduces binary deal risk. TBRG’s recurring revenue remains high at 94%, with stable cash flows and improved profitability despite flat top-line growth. The implied takeover valuation aligns with sector multiples, suggesting the upside is fundamentally supported, not purely speculative. Read the full article on Seeking AlphaNarrative Update • Apr 02
TBRG: Revenue Cycle Momentum And EHR Stability Will Support Future Re Rating
Analysts have trimmed their price targets on TruBridge, with the average moving from about $22.67 to $21.00 as they weigh a slightly higher discount rate, modestly different revenue growth and margin assumptions, and a lower future P/E multiple against the company's mix of Revenue Cycle Management growth potential and stable Electronic Health Records operations. Analyst Commentary Recent research updates on TruBridge reflect a mix of optimism around the business model and caution around execution and valuation.New Narrative • Apr 02
AI Expansion And Global Delivery Shift Will Shape A Steady But Capped Future
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and electronic health record solutions to hospitals and healthcare providers, with a particular focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Analysis Article • Feb 12
Returns At TruBridge (NASDAQ:TBRG) Appear To Be Weighed Down
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Narrative Update • Jan 28
TBRG: Revenue Cycle Focus And EHR Stability Will Test Execution Outcomes
Narrative Update The analyst price target for TruBridge has shifted modestly higher to about $22.67 per share, supported by analysts citing the potential of its Revenue Cycle Management focus alongside a steadier Electronic Health Records business, while still calling out execution risk after recent periods of low growth. Analyst Commentary Recent research points to a mixed but constructive view on TruBridge, with analysts focusing on the shift toward Revenue Cycle Management and the steadier Electronic Health Records business when considering valuation and execution risk.Narrative Update • Jan 12
TBRG: Revenue Cycle Realignment And EHR Stability Will Require Steady Execution
Narrative Update The analyst price target for TruBridge now centers around US$23, a modest lift from the prior US$22.60. Analysts point to the potential of the Revenue Cycle Management opportunity alongside a steadier Electronic Health Records business, while still flagging execution risk after recent periods of low growth.Narrative Update • Dec 17
TBRG: Revenue Cycle Shift Will Demand Proven Execution Before Rerating
Analysts raised their price target on TruBridge modestly, citing improving growth prospects from the company’s shift toward revenue cycle management as evidence builds of its long-term earnings potential. Analyst Commentary Bullish Takeaways Bullish analysts view the company’s realignment toward revenue cycle management as a structurally higher growth opportunity compared with its legacy clinical software offerings.Narrative Update • Dec 03
TBRG: Revenue Cycle Pivot Will Require Clear Execution Evidence In 2025
Analysts have nudged their price target on TruBridge slightly higher to approximately $22.60 per share. This reflects increased confidence that the company’s shift toward revenue cycle management can unlock more attractive, evidence-based growth than its legacy clinical software focus.Narrative Update • Nov 19
TBRG: Measured Optimism Will Depend On Evidence Of Execution In 2025
TruBridge's analyst price target has been revised downward from $24.75 to $22.60. Analysts cite recent coverage reflecting cautious optimism about the company's strategic shift toward revenue cycle management, while awaiting clearer evidence of execution before turning more positive.Analysis Article • Nov 14
Solid Earnings Reflect TruBridge's (NASDAQ:TBRG) Strength As A Business
Even though TruBridge, Inc.'s ( NASDAQ:TBRG ) recent earnings release was robust, the market didn't seem to notice. We...Narrative Update • Aug 15
AI And India Hub Will Boost Future Healthcare Efficiency
Despite a notable improvement in TruBridge’s net profit margin and a significant decline in its future P/E ratio, the consensus analyst price target has been sharply revised down from $29.25 to $24.75. What's in the News TruBridge lowered its full-year 2025 revenue guidance to $345 million-$350 million from a previous range of $345 million-$360 million; third quarter 2025 revenue is forecasted at $85 million-$87 million.New Narrative • May 31
Digital Automation And AI Will Drive Healthcare Transformation
Increased AI-driven automation, expanded SaaS offerings, and digital transformation are expected to boost operational efficiency, recurring revenue growth, and earnings quality.Analysis Article • Feb 14
Would TruBridge (NASDAQ:TBRG) Be Better Off With Less Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Jan 17
TruBridge, Inc. (NASDAQ:TBRG) Shares Fly 27% But Investors Aren't Buying For Growth
TruBridge, Inc. ( NASDAQ:TBRG ) shares have continued their recent momentum with a 27% gain in the last month alone...Analysis Article • Nov 13
TruBridge, Inc.'s (NASDAQ:TBRG) Business And Shares Still Trailing The Industry
TruBridge, Inc.'s ( NASDAQ:TBRG ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a buy right now...Analysis Article • Aug 05
Is TruBridge (NASDAQ:TBRG) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • May 25
Is TruBridge, Inc. (NASDAQ:TBRG) Trading At A 38% Discount?
Key Insights The projected fair value for TruBridge is US$16.15 based on 2 Stage Free Cash Flow to Equity Current share...Analysis Article • Feb 23
Computer Programs and Systems (NASDAQ:CPSI) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Sep 06
What Does Computer Programs and Systems, Inc.'s (NASDAQ:CPSI) Share Price Indicate?
Computer Programs and Systems, Inc. ( NASDAQ:CPSI ), is not the largest company out there, but it received a lot of...Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How TruBridge makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 346 | 4 | 105 | 32 |
| 31 Dec 25 | 347 | 4 | 100 | 33 |
| 30 Sep 25 | 347 | 3 | 101 | 33 |
| 30 Jun 25 | 345 | -11 | 101 | 33 |
| 31 Mar 25 | 345 | -18 | 98 | 33 |
| 31 Dec 24 | 342 | -20 | 96 | 35 |
| 30 Sep 24 | 337 | -59 | 86 | 37 |
| 30 Jun 24 | 335 | -54 | 77 | 39 |
| 31 Mar 24 | 334 | -52 | 84 | 40 |
| 31 Dec 23 | 337 | -47 | 104 | 39 |
| 30 Sep 23 | 337 | -1 | 80 | 36 |
| 30 Jun 23 | 337 | 5 | 88 | 33 |
| 31 Mar 23 | 335 | 11 | 81 | 32 |
| 31 Dec 22 | 327 | 16 | 78 | 32 |
| 30 Sep 22 | 317 | 18 | 77 | 31 |
| 30 Jun 22 | 305 | 19 | 76 | 32 |
| 31 Mar 22 | 290 | 22 | 71 | 30 |
| 31 Dec 21 | 281 | 18 | 70 | 33 |
| 30 Sep 21 | 273 | 16 | 71 | 31 |
| 30 Jun 21 | 272 | 18 | 69 | 32 |
| 31 Mar 21 | 263 | 14 | 70 | 34 |
| 31 Dec 20 | 264 | 14 | 70 | 33 |
| 30 Sep 20 | 268 | 22 | 68 | 34 |
| 30 Jun 20 | 269 | 20 | 68 | 35 |
| 31 Mar 20 | 275 | 20 | 71 | 36 |
| 31 Dec 19 | 275 | 20 | 71 | 37 |
| 30 Sep 19 | 276 | 16 | 75 | 37 |
| 30 Jun 19 | 277 | 18 | 76 | 37 |
| 31 Mar 19 | 279 | 17 | 77 | 37 |
| 31 Dec 18 | 280 | 17 | 78 | 36 |
| 30 Sep 18 | 286 | -11 | 82 | 36 |
| 30 Jun 18 | 284 | -15 | 81 | 35 |
| 31 Mar 18 | 284 | -13 | 81 | 34 |
| 31 Dec 17 | 277 | -17 | 80 | 34 |
| 30 Sep 17 | 263 | 6 | 75 | 34 |
| 30 Jun 17 | 261 | 5 | 75 | 34 |
| 31 Mar 17 | 262 | 6 | 73 | 34 |
| 31 Dec 16 | 267 | 4 | 72 | 29 |
| 30 Sep 16 | 247 | 5 | 63 | 27 |
| 30 Jun 16 | 227 | 7 | 61 | 22 |
| 31 Mar 16 | 206 | 11 | 55 | 18 |
| 31 Dec 15 | 182 | 18 | 52 | 14 |
| 30 Sep 15 | 184 | 21 | 50 | 11 |
| 30 Jun 15 | 193 | 27 | 47 | 7 |
Quality Earnings: TBRG has a large one-off loss of $10.0M impacting its last 12 months of financial results to 31st March, 2026.
Growing Profit Margin: TBRG became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TBRG's earnings have declined by 42.1% per year over the past 5 years.
Accelerating Growth: TBRG has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: TBRG has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (4.2%).
Return on Equity
High ROE: TBRG's Return on Equity (2.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/29 04:55 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
TruBridge, Inc. is covered by 23 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Stephanie Davis | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |